These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 9716152
1. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity. Salemink I, Franssen J, Willems GM, Hemker HC, Li A, Wun TC, Lindhout T. Thromb Haemost; 1998 Aug; 80(2):273-80. PubMed ID: 9716152 [Abstract] [Full Text] [Related]
2. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor. Iakhiaev A, Ruf W, Rao LV. Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815 [Abstract] [Full Text] [Related]
3. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor. Johnson K, Zaror I, Bauer D, Choi Y, Creasey A, Innis M. Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974 [Abstract] [Full Text] [Related]
4. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Cunningham AC, Hasty KA, Enghild JJ, Mast AE. Biochem J; 2002 Oct 15; 367(Pt 2):451-8. PubMed ID: 12117418 [Abstract] [Full Text] [Related]
5. Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes. Willems GM, Janssen MP, Salemink I, Wun TC, Lindhout T. Biochemistry; 1998 Mar 10; 37(10):3321-8. PubMed ID: 9521652 [Abstract] [Full Text] [Related]
6. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Ohkura N, Soe G, Kohno I, Kumeda K, Wada H, Kamikubo Y, Shiku H, Kato H. Blood Coagul Fibrinolysis; 1999 Sep 10; 10(6):309-19. PubMed ID: 10493212 [Abstract] [Full Text] [Related]
7. The importance of the binding of factor Xa to phospholipids in the inhibitory mechanism of tissue factor pathway inhibitor: the transmembrane and cytoplasmic domains of tissue factor are not essential for the inhibitory action of tissue factor pathway inhibitor. Kazama Y. Thromb Haemost; 1997 Mar 10; 77(3):492-7. PubMed ID: 9066000 [Abstract] [Full Text] [Related]
11. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor. Lindhout T, Franssen J, Willems G. Thromb Haemost; 1995 Sep 10; 74(3):910-5. PubMed ID: 8571320 [Abstract] [Full Text] [Related]
12. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes. Li A, Chang AC, Peer GT, Wun TC, Taylor FB. Thromb Haemost; 2001 May 10; 85(5):830-6. PubMed ID: 11372676 [Abstract] [Full Text] [Related]
15. Anticoagulant actions of tissue factor pathway inhibitor on tissue-factor-dependent plasma coagulation. Ofosu FA. Semin Thromb Hemost; 1995 May 10; 21(2):240-4. PubMed ID: 7660146 [Abstract] [Full Text] [Related]
16. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies. Nagase H, Enjyoji K, Kamikubo Y, Kitazato KT, Kitazato K, Saito H, Kato H. Thromb Haemost; 1997 Aug 10; 78(2):864-70. PubMed ID: 9268186 [Abstract] [Full Text] [Related]
17. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Wesselschmidt R, Likert K, Huang Z, MacPhail L, Broze GJ. Blood Coagul Fibrinolysis; 1993 Oct 10; 4(5):661-9. PubMed ID: 8292716 [Abstract] [Full Text] [Related]
20. Protein S as cofactor for TFPI. Hackeng TM, Rosing J. Arterioscler Thromb Vasc Biol; 2009 Dec 10; 29(12):2015-20. PubMed ID: 19661488 [Abstract] [Full Text] [Related] Page: [Next] [New Search]